Title:
婦人科系障害の治療のための、20,20,21,21,21-ペンタフルオロ-17-ヒドロキシ-11β-[4-(ヒドロキシアセチル)フェニル]-19-ノル-17α-プレグナ-4,9-ジエン-3-オン、及び1又は複数のプロゲストゲンの連続投与
Document Type and Number:
Japanese Patent JP2011520820
Kind Code:
A
Abstract:
Pharmaceutical combination preparation comprises single dose units of the progesterone receptor antagonists of 20,20,21,21,21-pentafluoro-17-hydroxy-11beta -[4-(hydroxyacetyl)phenyl]-19-nor-17alpha -pregna-4,9-dien-3-one (I) and individual dosage units of a gestagen to its sequential, oral administration for the treatment of gynecological diseases. An independent claim is included for a pharmaceutical preparation comprising (I), and information and direction for use, which is to begin with the next treatment cycle or after the onset of menstrual bleeding. ACTIVITY : Gynecological; Cytostatic. MECHANISM OF ACTION : Progesterone receptor antagonist.
More Like This:
Inventors:
Furman, Ulrike
Schwede, Wolfgang
Mailer, Karsten
Schwede, Wolfgang
Mailer, Karsten
Application Number:
JP2011508823A
Publication Date:
July 21, 2011
Filing Date:
May 07, 2009
Export Citation:
Assignee:
Bayer Schering Pharma Aktiengesellschaft
International Classes:
A61K31/567; A61P15/00; A61P35/00; C07J1/00
Attorney, Agent or Firm:
Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Masaru Nakajima
Ishizu relationship
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Masaru Nakajima
Ishizu relationship